Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance.
- NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_assertion wasGeneratedBy ECO_0000203 NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance.
- NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_assertion wasDerivedFrom befree-20140225 NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance.
- NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_assertion SIO_000772 17297461 NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance.
- NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_assertion evidence source_evidence_literature NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance.
- NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_assertion description "[CpG methylation-dependent silencing of SFRP1, SFRP2 and SFRP5 was frequently seen among GC cell lines (SFRP1, 16/16, 100%; SFRP2, 16/16, 100%; SFRP5, 13/16, 81%) and primary GC specimens (SFRP1, 42/46, 91%; SFRP2, 44/46, 96%; SFRP5, 30/46, 65%), and treatment with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine rapidly restored SFRP expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance.
- befree-20140225 importedOn "2014-02-25" NP174521.RAeMO98L1rNv_aqVNoi25585LWU0MsOmSLlrAEZmSGu6s130_provenance.